AAAAAA

   
Results: 1-11 |
Results: 11
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. (vol 6, pg 1176, 2000)
Authors: Kappos, L Comi, G Panitch, H Oger, J Antel, J Conlon, P Steinman, L
Citation: L. Kappos et al., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. (vol 6, pg 1176, 2000), NAT MED, 7(1), 2001, pp. 129-129
Re: Training residents for community psychiatric practice - The resident perspective
Authors: Conlon, P
Citation: P. Conlon, Re: Training residents for community psychiatric practice - The resident perspective, CAN J PSY, 46(6), 2001, pp. 561-561
Antigen specific immunotherapy of multiple sclerosis
Authors: Steinman, L Conlon, P
Citation: L. Steinman et P. Conlon, Antigen specific immunotherapy of multiple sclerosis, J CLIN IMM, 21(2), 2001, pp. 93-98
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
Authors: Kappos, L Comi, G Panitch, H Oger, J Antel, J Conlon, P Steinman, L
Citation: L. Kappos et al., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial, NAT MED, 6(10), 2000, pp. 1176-1182
Vitamin A induced stellate cell hyperplasia and fibrosis in renal failure
Authors: Doyle, S Conlon, P Royston, D
Citation: S. Doyle et al., Vitamin A induced stellate cell hyperplasia and fibrosis in renal failure, HISTOPATHOL, 36(1), 2000, pp. 90-91
Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency
Authors: Hemmer, B Pinilla, C Gran, B Vergelli, M Ling, N Conlon, P McFarland, HF Houghten, R Martin, R
Citation: B. Hemmer et al., Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency, J IMMUNOL, 164(2), 2000, pp. 861-871
In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenaseactivity in dogs
Authors: Kay-Mugford, P Benn, SJ LaMarre, J Conlon, P
Citation: P. Kay-mugford et al., In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenaseactivity in dogs, AM J VET RE, 61(7), 2000, pp. 802-810
The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system
Authors: Conlon, P Oksenberg, JR Zhang, JQ Steinman, L
Citation: P. Conlon et al., The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system, NEUROBIOL D, 6(3), 1999, pp. 149-166
Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs
Authors: Pasloske, K Renaud, R Burger, J Conlon, P
Citation: K. Pasloske et al., Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs, J VET PHARM, 22(5), 1999, pp. 314-319
Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis
Authors: Ruiz, PJ Garren, H Hirschberg, DL Langer-Gould, AM Levite, M Karpuj, MV Southwood, S Sette, A Conlon, P Steinman, L
Citation: Pj. Ruiz et al., Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis, J EXP MED, 189(8), 1999, pp. 1275-1283
Possible inconsistencies in study on cyclooxygenase
Authors: Kay-Mugford, T Conlon, P
Citation: T. Kay-mugford et P. Conlon, Possible inconsistencies in study on cyclooxygenase, AM J VET RE, 60(3), 1999, pp. 275-275
Risultati: 1-11 |